Skip to main content
Premium Trial:

Request an Annual Quote

TATAA to Sell TriLink's CleanAmp Products

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – TriLink Biotechnologies last week entered into a distribution agreement with TATAA Biocenter, under which Gothenburg, Sweden-based TATAA will sell TriLink's CleanAmp products.

TATAA develops and performs hands-on qPCR courses worldwide and provides tailor-made products for real-time PCR applications, the firm said in a statement.

TriLink's CleanAmp product line helps resolve common PCR problems, such as primer-dimer formation and mispriming. TriLink said that the latest addition to the product line, improved CleanAmp dNTPs, will be available next month. This new product enables improved amplicon yield in endpoint PCR and earlier Cq values in fast-cycling real-time PCR, the company said.

Financial and other terms of the alliance were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.